How Genzyme created the critical elements of #orphandrug success #raredisease

Possibly the most significant announcement in the orphan drug and rare disease industry in 2011 was Paris based pharmaceutical giant Sanofi's acquisition of Genzyme, a pioneer in the field of rare disease research. In 2011, the World Orphan Drug Congress was privileged to welcome the newly announced Chief Executive Officer of Genzyme, David Meeker to deliver an opening keynote to …